Wird geladen...
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
Idarucizumab (Praxbind) is a humanized antibody fragment, that reversibly and with high affinityties up dabigatran (Pradaxa). Anticoagulation reversal is achieved immediately, and with no procoagulant effect. It is administered intravenously and clearance is renal. The main clinical application of i...
Gespeichert in:
| Veröffentlicht in: | Vasc Health Risk Manag |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536811/ https://ncbi.nlm.nih.gov/pubmed/31213821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S181806 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|